Nektar Therapeutics
NKTR· Nasdaq
Released Mar 1, 2018, after the close
10-K filed Mar 1, 2018, 60 days after period end · 0001564590-18-004105
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $95.47M | $37.45M | $39.37M | $19.55M |
| Net Income | -$33.83M | -$42.20M | -$54.14M | -$45.68M |
| EPS Diluted | -$0.21 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.28 |
| -$0.40 |
| -$0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.